The NLRP1 inflammasome emerges as a promising therapeutic target and prognostic biomarker across multiple cancer types: A comprehensive pan-cancer analysis
Preprint in Research Square (May 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Preprint in Research Square (May 2024)
Conference proceeding (January 2024)
Article in Journal of Cancer Research and Clinical Oncology (June 2023)